Literature DB >> 28382512

Microsurgery guided by sequential preoperative lymphography using 68Ga-NEB PET and MRI in patients with lower-limb lymphedema.

Xiao Long1, Jingjing Zhang2,3, Daming Zhang4, Chao Gao1, Chongwei Chi5, Elan Yang1, Huadan Xue4, Lixin Lang3, Gang Niu3, Zhaohui Zhu6, Fang Li2, Xiaoyuan Chen7.   

Abstract

OBJECTIVE: The popularity of contemporary microsurgical techniques in treatment of lower-limb lymphedema calls for better visualization of the lymphatic system, both preoperatively and intra-operatively. The aim of this prospective study was to investigate the feasibility of a novel combination of 68Ga-NEB positron emission tomography (PET) with magnetic resonance lymphography (MRL) in evaluating lymphedema and guiding surgical intervention.
METHODS: A total of 11 patients (F 9, M 2, age range 29-69 y) with lower-limb lymphedema classified into stage I to III were recruited. PET acquisition was performed at 30, 60 and 90 min after subcutaneous injection of the albumin-binding radiotracer 68Ga-NEB into the bilateral first web spaces of the feet. All the patients were also subjected to 99mTc-sulfur colloid (SC) lymphoscintigraphy for comparison. Gd-DTPA-enhanced magnetic resonance imaging (MRI) was performed using sequences specialized for lymphatic vessel scans. All the patients underwent surgical interventions within a week. The surgical approach includes the use of a linear marker for edema localization and indocyanine green (ICG) lymphography with a near-infrared surgical navigation system intra-operatively.
RESULTS: Lymph transport in lymphatic channels was clearly observed by visualization of 68Ga-NEB activity in the lymphatic vessels and within lymph nodes for all 11 patients as well as the visualization of the edema section plane with dermal backflow (DB), abnormally increased and disconnected uptake along the lymphatic channels. Preoperative 68Ga-NEB PET combined with MRL provides advantageous three-dimensional images, higher temporal resolution, significantly shorter time lapse before image acquisition after tracer injection and more accurate pathological lymphatic vessel distribution than 99mTc-SC lymphoscintigraphy combined with MRI.
CONCLUSION: This study documented an effective imaging pattern to combine 68Ga-NEB PET and MRL in patients with lower-limb lymphedema. This strategy demonstrated significant advantage over 99mTc-SC lymphoscintigraphy/MRL in the evaluation of lymphedema severity, staging and pathological location of lymph vessels to make an individualized treatment plan. Dual 68Ga-NEB PET/MRL is thus recommended before the operation for staging and therapy planning.

Entities:  

Keywords:  68Ga-NEB; Evans blue dye; ICG; Lymphangiography; Lymphedema; PET-MR

Mesh:

Substances:

Year:  2017        PMID: 28382512      PMCID: PMC5507721          DOI: 10.1007/s00259-017-3676-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

Review 1.  The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology.

Authors: 
Journal:  Lymphology       Date:  2013-03       Impact factor: 1.286

2.  Groin dissection in malignant melanoma.

Authors:  C P Karakousis; D L Driscoll; B Rose; D L Walsh
Journal:  Ann Surg Oncol       Date:  1994-07       Impact factor: 5.344

Review 3.  Review of current surgical treatments for lymphedema.

Authors:  Jay W Granzow; Julie M Soderberg; Amy H Kaji; Christine Dauphine
Journal:  Ann Surg Oncol       Date:  2014-02-21       Impact factor: 5.344

Review 4.  Do surgical interventions for limb lymphoedema reduce cellulitis attack frequency?

Authors:  Amy R Sharkey; Samuel W King; Alexander J Ramsden; Dominic Furniss
Journal:  Microsurgery       Date:  2016-09-23       Impact factor: 2.425

5.  MR lymphangiography for the assessment of the lymphatic system in patients undergoing microsurgical reconstructions of lymphatic vessels.

Authors:  Christian Lohrmann; Gunther Felmerer; Etelka Foeldi; J-P Bartholomä; Mathias Langer
Journal:  Microvasc Res       Date:  2008-03-20       Impact factor: 3.514

Review 6.  Measurement Properties of Instruments for Measuring of Lymphedema: Systematic Review.

Authors:  Janine T Hidding; Peter B Viehoff; Carien H G Beurskens; Hanneke W M van Laarhoven; Maria W G Nijhuis-van der Sanden; Philip J van der Wees
Journal:  Phys Ther       Date:  2016-06-23

7.  Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging.

Authors:  Benjamin J Vakoc; Ryan M Lanning; James A Tyrrell; Timothy P Padera; Lisa A Bartlett; Triantafyllos Stylianopoulos; Lance L Munn; Guillermo J Tearney; Dai Fukumura; Rakesh K Jain; Brett E Bouma
Journal:  Nat Med       Date:  2009-09-13       Impact factor: 53.440

Review 8.  Lymphatic imaging: focus on imaging probes.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2015-03-18       Impact factor: 11.556

9.  Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes.

Authors:  Chongwei Chi; Qian Zhang; Yamin Mao; Deqiang Kou; Jingdan Qiu; Jinzuo Ye; Jiandong Wang; Zhongliang Wang; Yang Du; Jie Tian
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

Review 10.  Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology.

Authors:  Chongwei Chi; Yang Du; Jinzuo Ye; Deqiang Kou; Jingdan Qiu; Jiandong Wang; Jie Tian; Xiaoyuan Chen
Journal:  Theranostics       Date:  2014-08-15       Impact factor: 11.556

View more
  9 in total

1.  Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors.

Authors:  Jingjing Zhang; Hao Wang; Orit Jacobson; Yuejuan Cheng; Gang Niu; Fang Li; Chunmei Bai; Zhaohui Zhu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2018-04-13       Impact factor: 10.057

2.  68Ga-NOTA-Evans Blue TOF PET/MR Lymphoscintigraphy Evaluation of the Severity of Lower Limb Lymphedema.

Authors:  Guozhu Hou; Bo Hou; Yuanyuan Jiang; Zhaohui Zhu; Xiao Long; Xiaoyuan Chen; Wuying Cheng
Journal:  Clin Nucl Med       Date:  2019-06       Impact factor: 7.794

Review 3.  Innovations in lymph node targeting nanocarriers.

Authors:  Jihoon Kim; Paul A Archer; Susan N Thomas
Journal:  Semin Immunol       Date:  2021-11-24       Impact factor: 11.130

Review 4.  Imaging of the Lymphatic Vessels for Surgical Planning: A Systematic Review.

Authors:  Saskia van Heumen; Jonas J M Riksen; Wichor M Bramer; Gijs van Soest; Dalibor Vasilic
Journal:  Ann Surg Oncol       Date:  2022-09-28       Impact factor: 4.339

5.  Radioligand Therapy of Prostate Cancer with a Long-Lasting Prostate-Specific Membrane Antigen Targeting Agent 90Y-DOTA-EB-MCG.

Authors:  Zhantong Wang; Orit Jacobson; Rui Tian; Ronnie C Mease; Dale O Kiesewetter; Gang Niu; Martin G Pomper; Xiaoyuan Chen
Journal:  Bioconjug Chem       Date:  2018-06-15       Impact factor: 4.774

6.  Hemolymphangioma involving bones and bladder detected on 68Ga-NEB PET/CT: A rare case report.

Authors:  Guozhu Hou; Yuanyuan Jiang; Shan Jian; Yiru Niu; Wuying Cheng
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 7.  The bright future of nanotechnology in lymphatic system imaging and imaging-guided surgery.

Authors:  Shaolong Qi; Xinyu Wang; Kun Chang; Wenbin Shen; Guocan Yu; Jianshi Du
Journal:  J Nanobiotechnology       Date:  2022-01-06       Impact factor: 10.435

8.  Visual analysis of global research output of lymphedema based on bibliometrics.

Authors:  Yun-Dong Zhang; Xue Zhang; Xin-Yu Wang; Dong-Mei Han; Jian-Shi Du
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

9.  The relationship between the drainage function of inguinal lymph nodes and unilateral pelvic cancer-related lymphedema: A retrospective analysis.

Authors:  Guozhu Hou; Yuwei Zhang; Libo Chen; Fang Li; Hongli Jing
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.